Serum seleno-proteins status for colorectal cancer screening explored by data mining techniques - a multidisciplinary pilot study

Papp, 2007, From selenium to selenoproteins: synthesis, identity, and their role in human health, Antioxid. Redox Signal., 9, 775, 10.1089/ars.2007.1528 Parkin, 2005, Global Cancer Statistics, 2002, CA Cancer J. Clin., 55, 74, 10.3322/canjclin.55.2.74 Sciezka, 1997, Plasma selenium concentration in patients with stomach and colon cancer in the upper silesia, Neoplasma, 44, 395 Psathakis, 1998, Blood selenium and glutathione peroxidase status in patients with colorectal cancer, Dis. Colon Rectum, 41, 328, 10.1007/BF02237487 Milde, 2001, Serum levels of selenium, manganese, copper, and iron in colorectal cancer patients, Biol. Trace Elem. Res., 79, 107, 10.1385/BTER:79:2:107 Clark, 1993, Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps, Cancer Epidemiol. Biomarkers Prev., 2, 41 Russo, 1997, Plasma selenium levels and the risk of colorectal adenomas, Nutr. Cancer, 28, 125, 10.1080/01635589709514563 Fernández-Bañares, 2002, Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status, Am. J. Gastroenterol., 97, 2103, 10.1111/j.1572-0241.2002.05930.x Connelly-Frost, 2006, Selenium, Apoptosis, and Colorectal Adenomas, Cancer Epidemiol. Biomarkers Prev., 15, 486, 10.1158/1055-9965.EPI-05-0759 Dworkin, 1988, Selenium status and the polyp-cancer sequence: a colonoscopically controlled study, Am. J. Gastroenterol., 83, 748 Nelson, 1995, Serum selenium and colonic neoplastic risk, Dis. Colon Rectum, 38, 1306, 10.1007/BF02049157 Early, 2002, Selenoprotein levels in patients with colorectal adenomas and cancer, Am. J. Gastroenterol., 97, 745, 10.1111/j.1572-0241.2002.05558.x Wallace, 2003, Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case–control study, Cancer Epidemiol. Biomarkers Prev., 12, 464 Gromadzińska, 2008, Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements, Eur. J. Nutr., 47, 29, 10.1007/s00394-008-2005-z Taylor, 2005, Nutritional interventions in cancer prevention, J. Clin. Oncol., 23, 333, 10.1200/JCO.2005.06.190 Lopez-Saez, 2003, Selenium in breast cancer, Oncology, 64, 227, 10.1159/000069312 Hernández-Caraballo, 2005, Evaluation of chemometric techniques and artificial neural networks for cancer screening using Cu, Fe, Se and Zn concentrations in blood serum, Anal. Chim. Acta, 533, 161, 10.1016/j.aca.2004.10.087 Thomson, 1998, Selenium speciation in human body fluids, Analyst, 123, 827, 10.1039/a707292i Burk, 2001, Plasma selenium in specific and non-specific forms, Biofactors, 14, 107, 10.1002/biof.5520140115 Dumont, 2006, Selenium speciation from food source to metabolites: a critical review, Anal. Bioanal. Chem., 385, 1304, 10.1007/s00216-006-0529-8 2006, Selenium: Its molecular biology and role in human health Reid, 2006, Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial, Int. J. Cancer, 118, 1777, 10.1002/ijc.21529 Kumar, 1995, Decreased plasma glutathione in cancer of the uterine cervix, Cancer Lett., 94, 107, 10.1016/0304-3835(95)03832-H Persson-Moschos, 2000, Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men, Nutr. Cancer, 36, 19, 10.1207/S15327914NC3601_4 Silvera, 2007, Trace elements and cancer risk: a review of the epidemiologic evidence, Cancer Causes Control, 18, 7, 10.1007/s10552-006-0057-z Bellazzi, 2008, Predictive data mining in clinical medicine: current issues and guidelines, Int. J. Med. Inform., 77, 81, 10.1016/j.ijmedinf.2006.11.006 de Noo, 2006, Detection of colorectal cancer using MALDI-TOF serum protein profiling, Eur. J. Cancer, 42, 1068, 10.1016/j.ejca.2005.12.023 Selaru, 2002, Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions, Gastroenterology, 122, 606, 10.1053/gast.2002.31904 Frederiksen, 2003, Classification of Dukes' B and C colorectal cancers using expression arrays, J. Cancer Res. Clin. Oncol., 129, 263, 10.1007/s00432-003-0434-x Kim, 2004, Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas, Oncogene, 23, 6218, 10.1038/sj.onc.1207853 Mori, 2003, The impact of microsatellite instability on the molecular phenotype of colorectal tumors, Cancer Res., 63, 4577 Smith, 2007, Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy, Ann. Surg., 245, 259, 10.1097/01.sla.0000245577.68151.bd Cardoso, 2007, Expression and genomic profiling of colorectal cancer, Biochim. Biophys. Acta Rev. Cancer, 1775, 103, 10.1016/j.bbcan.2006.08.004 Jitaru, 2008, Simultaneous speciation analysis of glutathione peroxidase, selenoprotein P and selenoalbumin in human serum by tandem anion exchange-affinity HPLC and on-line isotope dilution ICP-quadrupole MS, Anal. Bioanal. Chem., 391, 661, 10.1007/s00216-008-2043-7 Cancer Staging Manual, 2002 Deschoolmeester, 2010, A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy, Oncologist, 15, 699, 10.1634/theoncologist.2010-0025 Shin, 2011, Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis, Ann. Surg. Oncol., 18, 2232, 10.1245/s10434-011-1612-8 Jass, 1987, A new prognostic classification of rectal cancer, Lancet, 329, 1303, 10.1016/S0140-6736(87)90552-6 Talbot, 1980, The clinical significance of invasion of veins by rectal cancer, Br. J. Surg., 67, 439, 10.1002/bjs.1800670619 Lindor, 2002, immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors, J. Clin. Oncol., 20, 1043, 10.1200/JCO.20.4.1043 Ogino, 2007, 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high, BMC Cancer, 7, 72, 10.1186/1471-2407-7-72 Umar, 2004, Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability, J. Natl. Cancer Inst., 96, 261, 10.1093/jnci/djh034 Half, 2009, Familial adenomatous polyposis, Orphanet. J. Rare Dis., 4, 22, 10.1186/1750-1172-4-22 2008, Epidemiology and medical statistics, 852 Kleinbaum, 2002 Rokach, 2008 Quinlan, 1993 Begg, 2006 Bishop, 2005 Fawcett, 2006, An introduction to ROC analysis, Pattern Recognit. Lett., 27, 861, 10.1016/j.patrec.2005.10.010 Hanley, 1983, A method of comparing the areas under receiver operating characteristic curves derived from the same cases, Radiology, 148, 839, 10.1148/radiology.148.3.6878708 Jacobson, 2006, Plasma glutathione peroxidase by ELISA and relationship to selenium level, Clin. Chim. Acta, 369, 100, 10.1016/j.cca.2006.01.007 Chan, 2005, Post-treatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiation, Int. J. Radiat. Oncol. Biol. Phys., 61, 665, 10.1016/j.ijrobp.2004.06.206 Wiesner, 2010, Colorectal Cancer, 457 Decensi, 2000, Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer, Eur. J. Cancer, 36, 694, 10.1016/S0959-8049(00)00040-X Ransohoff, 2005, Colon Cancer Screening in 2005: Status and Challenges, Gastroenterology, 128, 1685, 10.1053/j.gastro.2005.04.005 Gupta, 2008, Early detection of colon cancer: new tests on the horizon, Mol. Diagn. Ther., 12, 77, 10.1007/BF03256273 Reilly, 2006 Burk, 2005, Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis, Annu. Rev. Nutr., 25, 215, 10.1146/annurev.nutr.24.012003.132120 Schrauzer, 2002, Selenomethionine: a review of its nutritional significance, metabolism and toxicity (Reprinted from vol 130, pg 1653, 2000), J. Nutr., 132, 1653 Combs, 1998, Chemopreventive agents: selenium, Pharmacol. Ther., 79, 179, 10.1016/S0163-7258(98)00014-X Peters, 2006, High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program, Cancer Epidemiol. Biomarkers Prev., 15, 315, 10.1158/1055-9965.EPI-05-0471 Lloyd, 1983, Effect of smoking, alcohol, and other factors on the selenium status of a healthy population, J. Epidemiol. Community Health, 37, 213, 10.1136/jech.37.3.213 Persson-Moschos, 1998, Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium, Eur. J. Clin. Nutr., 52, 363, 10.1038/sj.ejcn.1600565 Allan, 1999, Responsiveness of selenoproteins to dietary selenium, Annu. Rev. Nutr., 19, 1, 10.1146/annurev.nutr.19.1.1 Duffield-Lillico, 2003, Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial, J. Natl. Cancer Inst., 95, 1477, 10.1093/jnci/djg061 Francescato, 1991, Selenium status in healthy Italian adults, J. Hum. Nutr. Diet., 4, 219, 10.1111/j.1365-277X.1991.tb00101.x Naito, 1998, CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer, Cancer Res., 58, 3491 Hawkes, 2001, The effects of dietary selenium on the immune system in healthy men, Biol. Trace Elem. Res., 81, 189, 10.1385/BTER:81:3:189 Ueno, 2002, Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer, Histopathology, 40, 127, 10.1046/j.1365-2559.2002.01324.x Kurt, 2008, Comparing performances of logistic regression, classification and regression tree, and neural networks for predicting coronary artery disease, Expert Syst. Appl., 34, 366, 10.1016/j.eswa.2006.09.004 Azuaje, 2010 Jitaru, 2010, Challenges in the accurate speciation analysis of selenium in humans: first report on indicative levels of selenoproteins in a serum certified reference material for total selenium (BCR-637), Accredit. Qual. Assur., 15, 343, 10.1007/s00769-010-0637-1